IMPORTANCE Despite being characterized as a disorder of language production, nonfluent/agrammatic variant primary progressive aphasia (nfvPPA) is frequently associated with auditory symptoms. However, to our knowledge, peripheral auditory function has not been defined in this condition. OBJECTIVE To assess peripheral hearing function in individuals with nfvPPA compared with healthy older individuals and patients with Alzheimer disease (AD).
N onfluent/agrammatic variant primary progressive aphasia (nfvPPA) is characterized as a disorder of language production. 1 Hearing in people with nfvPPA is not well characterized, but patients often experience difficulty following noisy and/or accented speech, word deafness, impaired recognition of voices and environmental sounds, and other symptoms potentially susceptible to auditory dysfunction. [1] [2] [3] [4] [5] Besides its implications for the neurobiology and diagnosis of primary progressive aphasia, characterization of auditory dysfunction in patients with nfvPPA might help elucidate the potentiating role of hearing impairment in other neurodegenerative disorders (eg, Alzheimer disease [AD]). 2, 6 Here we assessed peripheral hearing using pure-tone audiometry in patients with nfvPPA compared with healthy control participants and patients with AD.
Methods

Participant Characteristics
We recruited patients with nfvPPA, patients with AD, and control participants between August 2015 and July 2018. All patients fulfilled diagnostic criteria, 7 supported by neuropsychological assessment and brain magnetic resonance imaging (eMethods in the Supplement). No participant had a history of substantial otological disease or major comorbid cerebrovascular burden.
Ethical approval was granted by the University College London and National Hospital for Neurology and Neurosurgery research ethics committees. All participants gave informed consent consistent with Declaration of Helsinki guidelines.
Audiometry Procedure
We adapted a standard clinical audiometry protocol 8 assessing frequencies 500, 1000, 2000, 4000, and 6000 Hz (details in the Supplement). The participant's mean threshold level for detecting each frequency was recorded in each ear.
Data Analyses
Demographic and clinical characteristics were compared between groups using analysis of variance and Fisher exact tests. Audiometry data were analyzed by adapting a previously described protocol. 6 For each participant, composite left-ear mean, rightear mean, better-ear mean (BEM), and worse-ear mean (WEM) threshold and interaural difference scores were calculated across mean threshold levels for all frequencies. These scores were compared between groups using analysis of covariance models, with participant age as a covariate; pairwise group differences were assessed using planned comparisons that also adjusted for age. We conducted a separate analysis relaxing normality and homoscedasticity assumptions to check robustness (eTable in the Supplement). For descriptive purposes, we created categorical scores for each composite mean, with scores of 20 to 40 dB categorized as mild hearing loss, and scores greater than 41 dB categorized as moderate hearing loss. 8 We used Spearman ρ to assess associations between age and both BEM and WEM scores across the entire cohort, and a series of partial correlation analyses (controlling for age) assessing as-sociations between BEM and WEM scores and clinical duration, severity (via Mini-Mental State Examination [MMSE] score), and nonverbal executive function (Wechsler Abbreviated Scale of Intelligence [WASI] matrix reasoning score) in the combined patient cohort; and with measures of speech apraxia (polysyllabic word repetition score) and agrammatism (written sentence construction score) in the nfvPPA group. An α level of .05 was used as the statistical significance threshold. Data were analyzed with Stata version 14 (StataCorp).
Results
Nineteen patients with nfvPPA, 20 patients with AD, and 34 control participants participated ( Table 1 ). The control participants had a younger mean (SD) age (66.7 [6.3] 
Key Points
Question What is the status of peripheral hearing in patients with nonfluent/agrammatic variant primary progressive aphasia (nfvPPA)?
Findings Patients with nfvPPA performed worse on pure-tone audiometry than healthy older individuals or patients with Alzheimer disease, after controlling for age and general disease factors. In addition, these patients showed increased functional interaural audiometric asymmetry.
Meaning Auditory system involvement in patients with nfvPPA is more substantial than previously recognized.
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Findings of Impaired Of 34 control participants, 4 each had moderate hearing loss in the left ear (12%) and the right ear (12%). Of the 20 participants with AD, 5 had moderate hearing loss in the left ear (25%) and 3 in the right ear (16%). Of 19 patients with nfvPPA, moderate hearing loss was present in the left ear in 7 individuals (37%) and in the right ear in 7 individuals (39%).
There was also evidence of differences among the 3 groups in WEM-BEM difference scores (mean (SD): control group, 2.7 [2.2] Across the combined participant cohort, age was associated with WEM scores (ρ = 0.48; P < .001) and BEM scores (ρ = 0.46; P < .001). Across the patient cohort, after adjusting for age, there were no significant effects of disease duration, MMSE, WASI matrices, or language production scores on WEM scores (duration partial r =−0.18; P = .30; MMSE, partial r = 0.04; P = .82; WASI matrices, partial r = 0.08; P = .66; word repetition, partial r = −0.34; P = .30; sentence construction, partial r =−0.45; P = .17) or BEM scores (duration, partial r = −0.10; P = .56; MMSE, partial r = 0.10; P = .55; WASI matrices, partial r = 0.21; P = .23; word repetition, partial r = −0.12; P = .72; sentence construction, partial r =−0.32;P = .34).
Discussion
In this analysis, we present evidence that patients with nfvPPA perform worse on pure-tone audiometry than healthy older individuals or patients with AD. These data suggest that this is not attributable to age or general disease factors. Moreover, nfvPPA was associated with increased interaural functional asymmetry, not lateralized to the right ear or left ear. The role of the auditory system in this language-led dementia has not been defined. These findings suggest that auditory pathway involvement in nfvPPA is more significant than generally recognized, corroborating the diverse hearing alterations (extending to environmental sounds and music) previously reported in these patients [1] [2] [3] [4] [5] [9] [10] [11] and proposed to contribute to the pathogenesis of nfvPPA. 4, 10 While this study has not defined the neural substrate for audiologic impairment in nfvPPA, there are several candidates. Impaired pure-tone audiometry usually signifies peripheral auditory dysfunction; most cases of nfvPPA are underpinned by tauopathy (encompassing corticobasal degeneration and progressive supranuclear palsy 1 ; Table 1 ), and brainstem and subcortical pathways, including auditory pathways, are vulnerable to this pathology. However, involvement of peripheral auditory afferents in tauopathies does not necessarily produce audiologic deficits. 12 Audiologic impairment in individuals with nfvPPA might additionally reflect involvement of cerebral integrative or brainstem efferent regulatory processes, such as those involved in auditory target detection. 13, 14 Any such dysregulatory effect would tend to be amplified in background noise, consistent with clinical observations. 1, 2 The finding of increased interaural functional asymmetry in individuals with nfvPPA is unlikely to be attributable to cochlear or auditory nerve pathology and implicates more central pathways, although its mechanism remains to be established.
Future work should address the mechanism of audiologic impairment in individuals with nfvPPA in association with cognitive and speech output functions in this syndrome and effects on patients' daily lives. Auditory processing in these patients should be further characterized, both physiologically (including tympanometry, otoacoustic emissions, brainstem auditory evoked potentials, dichotic listening, and other central hearing tasks) and neuroanatomically (including structural and functional neuroimaging techniques) to establish the nature and locus of their hearing impairment.
Conclusions
Consistent with recent work, 2,4,10 these findings suggest that patients with nfvPPA have a disorder of communication signal processing that extends beyond neurolinguistic impairment; it may be timely to reevaluate the progressive aphasias from this fresh perspective. As a paradigm of selective neural system degeneration, nfvPPA could serve as a model disor- Research Brief Report Findings of Impaired Hearing in Patients With Nonfluent/Agrammatic Variant Primary Progressive Aphasia der for interpreting the interplay of peripheral hearing and cognitive function in neurodegenerative disease and evaluating physiologically informed hearing and communication therapies in people with dementia. These could include interven-tions to improve the fidelity of auditory signal processing in noisy environments and harness residual plasticity in the damaged auditory system, an approach that shows early promise in patients with AD. 15
eMethods. Details of audiometry procedure
Using an Otovation Roto® audiometer (https://www.auditdata.com/) with a single TDH-39P 10-ohm Telephonics® earphone (www.telephonics.com) in a quiet room, steady tones of 500, 1000, 2000, 4000 and 6000Hz were presented separately to each ear, over ascending intensity levels commencing at 20dB HL (decibel hearing level). At each frequency, the participant indicated (verbally or by gesture) when they first heard a noise. If the participant was unable to hear the tone, the level was increased in 5dB increments (maximum 70dB HL). This procedure was repeated three times.
eTable. Comparisons of group audiometric data relaxing normality assumptions.
a Data for one participant with AD and one participant with nfvPPA were only available for left ear. AD, patient group with typical Alzheimer's disease; BEM, better ear mean score; dB, decibels; diff, difference;
LEM, left ear mean score; nfvPPA, patient group with nonfluent/agrammatic variant primary progressive aphasia; REM, right ear mean score; WEM, worse ear mean score. Peripheral hearing composite scores for each participant were calculated by taking the mean threshold level required to hear tones at frequencies of 500, 1000, 2000, 4000, and 6000 Hz.
The main manuscript reports results from parametric Analysis of Covariance (ANCOVA) models. In a separate analysis, we adopted a permutation approach attributable to Freedman & Lane 1 . This approach gives the same parameter estimates as ANCOVA but with p-values relaxing the normality and homoscedasticity assumptions made by ANCOVA; the p-values for the overall effect of diagnosis reported here were computed using 100000 permutations of residuals from age-adjusted models. We also calculated non-parametric bias corrected and accelerated bootstrap confidence intervals 2 for the between group differences based on 100000 bootstrap resamples; these also relax assumptions of normality and homoscedasticity. Results from this more conservative approach (tabulated here) were very similar to those using conventional ANCOVA models; albeit that the bootstrap confidence intervals for comparisons involving the nfvPPA group are typically (marginally) wider, and those for the AD vs Controls comparison are (marginally) narrower, than the parametric equivalents, but differences are all minor.
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